Presentation TCT 2016 TCT 516: Instantaneous-wave Free Ratio and Fractional Flow Reserve Comparison in Patients with and Without Severe Aortic Valve Stenosis. Presenter: Alan C. Yeung, Tim P. van de Hoef November 01, 2016
Presentation TCT 2016 TCT 412: Long-term Clinical Outcomes of Transient and Persistent No-Reflow Following Percutaneous Coronary Intervention (PCI): Insights from a Multi-center Australian Registry Presenter: Mauricio G. Cohen, Bernhard Witzenbichler November 01, 2016
Presentation TCT 2016 TCT 597: Why Does Thin-Cap Fibroatheroma Cluster in the Proximal egment in Left Anterior Coronary Artery, But Are Evenly Distributed Throughout the Entire Right Coronary Artery? Results from Computational Fluid Dynamics Simulation by CT-FFR Presenter: Eric Boersma, James E. Muller November 01, 2016
Presentation TCT 2016 FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways Presenter: Nicole Ibrahim, Martin B. Leon, Jaime Raben November 01, 2016
Presentation TCT 2016 Pulmonary Artery Denervation for Chronic Pulmonary Hypertension I: Experimental Insights Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Alex M. K. Rothman November 01, 2016
Presentation TCT 2016 My Best Antegrade Case(s) of the Last Year Presenter: Colm Hanratty, Paul Hsien-Li Kao, Jianfang Luo November 01, 2016
Presentation TCT 2016 Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic AF Patient Who Requires PCI Presenter: David P. Faxon, C. Michael Gibson, Deepak L. Bhatt November 01, 2016
Presentation TCT 2016 Venous Access Specifics: Puncture, Sheath Introduction, Traversing the IVC, and Puncture Site Closure Presenter: Maurice Buchbinder, Saibal Kar, Sameer Gafoor November 01, 2016
Presentation TCT 2016 Interatrial Shunts: Theoretical Basis and Unanswered Questions Presenter: Josep Rodés-Cabau, Nir Uriel, Daniel Burkhoff November 01, 2016
Presentation TCT 2016 Lotus and EDGE: Design Features, Special Attributes, and Clinical Trial Program Presenter: Eberhard Grube, James B. Hermiller Jr., Ted Feldman November 01, 2016
Presentation TCT 2016 Metallic Versus Polymeric BRS: Differences In Mechanical Properties and Preclinical Bench Testing Presenter: Stephen G. Ellis, Patrick W. Serruys, Ron Waksman November 01, 2016
Presentation TCT 2016 Atrial Septostomy for Chronic Pulmonary Hypertension Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Gagan D Singh November 01, 2016
Presentation TCT 2016 When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy? Presenter: David P. Faxon, C. Michael Gibson, Roxana Mehran November 01, 2016
Presentation TCT 2016 Impact of the Learning Curve on BRS Outcomes: Experience From the GABI-R Registry Presenter: Stephen G. Ellis, Patrick W. Serruys, Holger M. Nef November 01, 2016
Presentation TCT 2016 Surgical Therapy for Chronic Pulmonary Thromboembolic Disease: Does it Work? Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Matthew D. Bacchetta November 01, 2016
Presentation TCT 2016 Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results) Presenter: Philip M. Urban, Stephen G. Worthley, Robert-Jan van Geuns November 01, 2016
Presentation TCT 2016 Impact of Implant Technique on Scaffold Thrombosis: The MICAT Experience Presenter: Stephen G. Ellis, Patrick W. Serruys, Serban Puricel November 01, 2016
Presentation TCT 2016 Portico: Design Features, Special Attributes, and Clinical Trial Program Presenter: Eberhard Grube, James B. Hermiller Jr., Raj Makkar November 01, 2016
Presentation TCT 2016 Hybrid/Guide Extension Reverse CART Presenter: Alfredo R. Galassi, Masahiko Ochiai, Paul Knaapen November 01, 2016
Presentation TCT 2016 Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding Presenter: David P. Faxon, C. Michael Gibson November 01, 2016